FUS and liposarcoma: Fused in sarcoma (FUS)/Translocated in Sarcoma (TLS) was first identified as a fusion oncogene in human liposarcomas, which is composed of the FUS residues 1–266 fused with a transcription factor C/EBP Homologous protein (CHOP) [1,2].